Oklahoma Healthcare Wire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oklahoma Healthcare Wire.

Press releases published on June 22, 2026

an hour ago

CurePSP Expands Grant Program with $155,000 Investment in Studying Care for Rare Neurological Diseases

Indeterminate GlobeNewswire

an hour ago

Weight Watchers to Support the American Heart Association’s Healthy Living BEYOND Weight Study

Indeterminate GlobeNewswire

an hour ago

Creative Medical Technology Holdings Expands ADAPT Trial Under New FDA Clearance and Rapidly Advances Toward Phase 3 Planning for Olastrocel in Chronic Lower Back Pain

Indeterminate GlobeNewswire

an hour ago

Marius Pharmaceuticals Applauds FDA’s Proposed Testosterone Labeling Updates as a Turning Point for Men’s Health

Indeterminate GlobeNewswire

an hour ago

INVO Fertility Reports First Quarter 2026 Results Reflecting Strong Revenue Growth, Expanded Fertility Clinic Platform, and Improved Capital Structure

Indeterminate GlobeNewswire

an hour ago

Parexel Launches Parexel Biotech Incubator to Connect Early-Stage Innovation with Clinical Development Expertise

Indeterminate GlobeNewswire

2 hours ago

InterCure Secures NIS 22 Million in Private Placement Financing Led by Leading Pharma-Focused Hedge Funds

Indeterminate GlobeNewswire

2 hours ago

AIM ImmunoTech to Present in the Webull Corporate Connect Webinar Series

Indeterminate GlobeNewswire

2 hours ago

Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.14 Billion

Indeterminate GlobeNewswire

2 hours ago

Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA

Indeterminate GlobeNewswire

2 hours ago

Next-Generation DNA Repair Therapies Open New Frontiers in Oncology

Indeterminate GlobeNewswire

2 hours ago

Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis

Indeterminate GlobeNewswire

2 hours ago

FibroBiologics Receives Notice of Allowance for U.S. Patent Covering Topical Fibroblast Spheroid Therapy for Wound Healing

Indeterminate GlobeNewswire

2 hours ago

Entera Bio Receives Positive FDA Feedback on 12-Month Registrational Phase 3 Study for EB613 - the First Oral Anabolic Tablet in Development for Postmenopausal Women with Osteoporosis

Indeterminate GlobeNewswire

2 hours ago

NewGen Issues 3,666,667 New Shares in Connection with Strategic K25.ai Acquisition, Reaches Milestone of US$7.6 Million Market Capitalization

Indeterminate GlobeNewswire

2 hours ago

Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity

Indeterminate GlobeNewswire

2 hours ago

Clearmind Medicine Reaches Major Milestone, Completing Part A Treatment in FDA‑Regulated Phase I/II Trial

Indeterminate GlobeNewswire

2 hours ago

Verrica Pharmaceuticals Announces First U.S. Patient Dosed in the Second Pivotal Clinical Trial (COVE-3) of its Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts 

Indeterminate GlobeNewswire

2 hours ago

Novel Key Terms For Managing CIDP Published in Neurology® Journal

Indeterminate GlobeNewswire

2 hours ago

Medidata Unveils New Academic Board to Bridge the Gap Between Research and Patient Care

Indeterminate GlobeNewswire